Rankings
▼
Calendar
NAUT (Nautilus Biotechnology, Inc.) Stock Financials & Earnings | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
Mkt Cap
$339M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$59M
EPS (TTM)
-$0.47
Free Cash Flow (TTM)
-$52M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
-$1M
-$18M
Q2 23
$0
-$1M
-$19M
Q3 23
$0
-$2M
-$19M
Q4 23
$0
-$2M
-$20M
Q1 24
$0
-$2M
-$22M
Q2 24
$0
-$2M
-$21M
Q3 24
$0
-$2M
-$19M
Q4 24
$0
-$6M
-$20M
Q1 25
$0
-$2M
-$19M
Q2 25
$0
-$2M
-$17M
Q3 25
$0
-$2M
-$15M
Q4 25
$0
-$2M
-$15M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$13M
-$13M
Q2 23
-$14M
-$14M
Q3 23
-$12M
-$13M
Q4 23
-$14M
-$14M
Q1 24
-$16M
-$17M
Q2 24
-$15M
-$16M
Q3 24
-$13M
-$14M
Q4 24
-$14M
-$15M
Q1 25
-$14M
-$14M
Q2 25
-$13M
-$14M
Q3 25
-$11M
-$11M
Q4 25
-$12M
-$13M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$692K
Q2 23
$463K
Q3 23
$874K
Q4 23
$413K
Q1 24
$647K
Q2 24
$512K
Q3 24
$709K
Q4 24
$254K
Q1 25
$219K
Q2 25
$396K
Q3 25
$418K
Q4 25
$244K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+12.7%
Q2 23
—
+22.9%
Q3 23
—
+20.6%
Q4 23
—
+22.7%
Q1 24
—
+19.6%
Q2 24
—
+9.3%
Q3 24
—
+0.1%
Q4 24
—
-0.1%
Q1 25
—
-12.8%
Q2 25
—
-17.8%
Q3 25
—
-19.0%
Q4 25
—
-22.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
—
Q2 23
$0
—
Q3 23
$3M
—
Q4 23
$3M
—
Q1 24
$3M
—
Q2 24
$3M
—
Q3 24
$3M
—
Q4 24
$3M
—
Q1 25
$2M
—
Q2 25
$2M
—
Q3 25
$1M
—
Q4 25
$1M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$10M
—
$6M
Q2 23
$12M
—
$6M
Q3 23
$11M
—
$6M
Q4 23
$12M
—
$7M
Q1 24
$12M
—
$8M
Q2 24
$12M
—
$7M
Q3 24
$12M
—
$6M
Q4 24
$11M
—
$3M
Q1 25
$11M
—
$6M
Q2 25
$10M
—
$6M
Q3 25
$9M
—
$5M
Q4 25
$11M
$26M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$89M
$79M
$167M
Q2 23
$72M
$91M
$163M
Q3 23
$74M
$109M
$183M
Q4 23
$19M
$154M
$173M
Q1 24
$26M
$156M
$181M
Q2 24
$25M
$143M
$167M
Q3 24
$4M
$136M
$141M
Q4 24
$28M
$102M
$130M
Q1 25
$33M
$106M
$139M
Q2 25
$34M
$113M
$148M
Q3 25
$24M
$108M
$131M
Q4 25
$12M
$91M
$103M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
125M
-0.2%
Q2 23
125M
+0.0%
Q3 23
125M
+0.3%
Q4 23
125M
+0.0%
Q1 24
125M
+0.1%
Q2 24
125M
+0.1%
Q3 24
125M
+0.1%
Q4 24
126M
+0.3%
Q1 25
125M
-0.7%
Q2 25
126M
+1.0%
Q3 25
126M
+0.0%
Q4 25
126M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$0
3
FY 21
$0
113
FY 22
$0
134
FY 23
$0
167
FY 24
$0
155
FY 25
$0
130
marketcaparena.com